(19)
(11) EP 1 922 082 A2

(12)

(88) Date of publication A3:
12.07.2007

(43) Date of publication:
21.05.2008 Bulletin 2008/21

(21) Application number: 06802036.1

(22) Date of filing: 21.08.2006
(51) International Patent Classification (IPC): 
A61K 38/26(2006.01)
(86) International application number:
PCT/US2006/032661
(87) International publication number:
WO 2007/022518 (22.02.2007 Gazette 2007/08)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 19.08.2005 US 709647 P
19.08.2005 US 709604 P
03.03.2006 US 779216 P
18.08.2006 US 32354 P

(71) Applicant: AMYLIN PHARMACEUTICALS, INC.
San Diego, CA 92121 (US)

(72) Inventors:
  • BARON, Alain, D.
    San Diego, CA 92121 (US)
  • MAGGS, David
    San Diego, California 92121 (US)
  • KIM, Dennis
    San Diego, CA 92121 (US)
  • WINTLE, Matthew
    San Diego, CA 92121 (US)

(74) Representative: UEXKÜLL & STOLBERG 
Patentanwälte Beselerstrasse 4
22607 Hamburg
22607 Hamburg (DE)

   


(54) NEW USES OF GLUCOREGULATORY PROTEINS